Recent
reports have revealed the intrinsic propensity of single
aromatic metabolites to undergo self-assembly and form nanostructures
of amyloid nature. Hence, identifying whether aspartame, a universally
consumed artificial sweetener, is inherently aggregation prone becomes
an important area of investigation. Although the reports on aspartame-linked
side effects describe a multitude of metabolic disorders, the mechanistic
understanding of such destructive effects is largely mysterious. Since
aromaticity, an aggregation-promoting factor, is intrinsic to aspartame’s
chemistry, it is important to know whether aspartame can undergo self-association
and if such a property can predispose any cytotoxicity to biological
systems. Our study finds that aspartame molecules, under mimicked
physiological conditions, undergo a spontaneous self-assembly process
yielding regular β-sheet-like cytotoxic nanofibrils of amyloid
nature. The resultant aspartame fibrils were found to trigger amyloid
cross-seeding and become a toxic aggregation trap for globular proteins,
Aβ peptides, and aromatic metabolites that convert native structures
to β-sheet-like fibrils. Aspartame fibrils were also found to
induce hemolysis, causing DNA damage resulting in both apoptosis and
necrosis-mediated cell death. Specific spatial arrangement between
aspartame molecules is predicted to form a regular amyloid-like architecture
with a sticky exterior that is capable of promoting viable H-bonds,
electrostatic interactions, and hydrophobic contacts with biomolecules,
leading to the onset of protein aggregation and cell death. Results
reveal that the aspartame molecule is inherently amyloidogenic, and
the self-assembly of aspartame becomes a toxic trap for proteins and
cells, exposing the bitter side of such a ubiquitously used artificial
sweetener.